Wixela Inhub: A Generic Equivalent Treatment Option for Patients with Asthma or COPD.

James F DonohueDouglas S BurgoyneJonathan K WardRichard Allan Arkady Koltun Andrew Cooper

Published in: Pulmonary therapy (2020)

The bioequivalence demonstrated by the totality of clinical and in vitro data supports the use of Wixela Inhub and provides a treatment option for patients with asthma or COPD.

Keyphrases

chronic obstructive pulmonary disease
lung function
deep learning
replacement therapy
data analysis